1-(5-isoquinolinesulfonyl)-2-methylpiperazine has been researched along with Dementia Praecox in 1 studies
1-(5-Isoquinolinesulfonyl)-2-Methylpiperazine: A specific protein kinase C inhibitor, which inhibits superoxide release from human neutrophils (PMN) stimulated with phorbol myristate acetate or synthetic diacylglycerol.
1-(5-isoquinolinesulfonyl)-2-methylpiperazine : A member of the class of N-sulfonylpiperazines that is 2-methylpiperazine substituted at position 1 by a 5-isoquinolinesulfonyl group.
Excerpt | Relevance | Reference |
---|---|---|
"Current antipsychotics used to treat schizophrenia have associated problems, including serious side effects and treatment resistance." | 5.72 | Antipsychotic-like effects of fasudil, a Rho-kinase inhibitor, in a pharmacologic animal model of schizophrenia. ( Kaibuchi, K; Liao, J; Liu, Y; Miyagawa, Y; Mizoguchi, H; Nagai, T; Ozaki, N; Sawahata, M; Sobue, A; Takase, S; Tanaka, R; Yamada, K, 2022) |
"Current antipsychotics used to treat schizophrenia have associated problems, including serious side effects and treatment resistance." | 1.72 | Antipsychotic-like effects of fasudil, a Rho-kinase inhibitor, in a pharmacologic animal model of schizophrenia. ( Kaibuchi, K; Liao, J; Liu, Y; Miyagawa, Y; Mizoguchi, H; Nagai, T; Ozaki, N; Sawahata, M; Sobue, A; Takase, S; Tanaka, R; Yamada, K, 2022) |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 1 (100.00) | 2.80 |
Authors | Studies |
---|---|
Takase, S | 1 |
Liao, J | 1 |
Liu, Y | 1 |
Tanaka, R | 1 |
Miyagawa, Y | 1 |
Sawahata, M | 1 |
Sobue, A | 1 |
Mizoguchi, H | 1 |
Nagai, T | 1 |
Kaibuchi, K | 1 |
Ozaki, N | 1 |
Yamada, K | 1 |
1 other study available for 1-(5-isoquinolinesulfonyl)-2-methylpiperazine and Dementia Praecox
Article | Year |
---|---|
Antipsychotic-like effects of fasudil, a Rho-kinase inhibitor, in a pharmacologic animal model of schizophrenia.
Topics: 1-(5-Isoquinolinesulfonyl)-2-Methylpiperazine; Animals; Antipsychotic Agents; Disease Models, Animal | 2022 |